logo

For the Inventor, By the Inventor

Tournefeuille, France

Jean Marc Herbert

This inventor holds 14 USPTO granted patents and 1 published patent application. Top assignees: Sanofi-Synthelabo, Sanofi, Sanofi-Aventis. Active years: 1999-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean Marc Herbert. Retrieved from https://idiyas.com/inventor/jean-marc-herbert-5ubd0cq1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 57.1

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 83(Granted Patents)


Location History:

  • Tourefeuille, FR (2003)
  • Tournefeuille, FR (1999 - 2014)

Company Filing History:

goldMedal4 out of 152 
 
Sanofi-Synthelabo
 patents
silverMedal3 out of 1,547 
 
Sanofi
 patents
bronzeMedal3 out of 390 
 
Sanofi-Aventis
 patents
4. 1 out of 1,248 
 
Akzo Nobel N.v.
 patents
5. 1 out of 1 
 
Azko Nobel
 patent
6. 3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2014

Loading Chart...
14 patents (USPTO):Explore Patents
1. 8703738 - Biotinylated hexadecasaccharides, preparation and use thereof (2014-04-22),
2. 8557968 - Biotinylated hexadecasaccharides, preparation and use thereof (2013-10-15),
3. 7943595 - Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative (2011-05-17),
4. 7919614 - Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them (2011-04-05),
5. 7320982 - Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 (2008-01-22),
6. 6693118 - Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-&bgr;1 (2004-02-17),
7. 6541488 - Compositions for treating arterial thrombosis and a factor Xa inhibitor (2003-04-01),
8. 6534481 - Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same (2003-03-18),
9. 6528497 - Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same (2003-03-04),
10. 6482986 - Benzene derivatives, preparation method and pharmaceutical compositions containing same (2002-11-19),
11. 6391339 - Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits (2002-05-21),
12. 6342505 - Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-&bgr;1 (2002-01-29),
13. 6218403 - Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an HMG-CoA-reductase inhibitor (2001-04-17),
14. 5989578 - Associations of active principles containing clopidogrel and an (1999-11-23),

Title: Innovations of Jean Marc Herbert

Introduction

Jean Marc Herbert is a notable inventor based in Tournefeuille, France. He holds a total of 14 patents, showcasing his significant contributions to the field of biochemistry and pharmaceuticals. His work primarily focuses on novel biotinylated hexadecasaccharides, which have potential applications in medicine.

Latest Patents

One of his latest patents is titled "Biotinylated hexadecasaccharides, preparation and use thereof." This invention concerns novel biotinylated hexadecasaccharides of general formula (I), wherein Biot is a biotin derivative. The components R, R, and R represent independently a C-Calkoxy or an —OSO. Additionally, R can represent a C-Calkoxy or an —OSO, or it can constitute a —O—CH— bridge. The element Pe represents a saccharide concatenation, along with their pharmaceutically acceptable salts, and their use as medicines.

Career Highlights

Throughout his career, Jean Marc Herbert has worked with prominent companies such as Sanofi-Synthelabo and Sanofi. His experience in these organizations has contributed to his expertise in the development of innovative pharmaceutical solutions.

Collaborations

He has collaborated with notable coworkers, including Maurice Petitou and Philippe Duchaussoy, who have also made significant contributions to the field.

Conclusion

Jean Marc Herbert's work in biochemistry, particularly with biotinylated hexadecasaccharides, highlights his innovative spirit and dedication to advancing medical science. His numerous patents reflect his commitment to developing effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…